# Why Oscar Health's 'Great Quarter' Isn't What It Looks Like

Page: https://stenobird.com/podcast/chip-stock-investor-podcast-6441813/why-oscar-health-s-great-quarter-isn-t-what-it-looks-like
Text version: https://stenobird.com/podcast/chip-stock-investor-podcast-6441813/why-oscar-health-s-great-quarter-isn-t-what-it-looks-like.md
Podcast: [Chip Stock Investor Podcast](https://stenobird.com/podcast/chip-stock-investor-podcast-6441813)
Published: 2026-09-10T04:55:24+00:00
Episode link: https://podcasters.spotify.com/pod/show/chipstockinvestor/episodes/Why-Oscar-Healths-Great-Quarter-Isnt-What-It-Looks-Like-e3ojmfq
Audio file: https://anchor.fm/s/e2cacf78/podcast/play/125474746/https%3A%2F%2Fd3ctxlq1ktw2nl.cloudfront.net%2Fstaging%2F2026-8-9%2F431542269-44100-2-549346be06766.mp3
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/chip-stock-investor-podcast-6441813/episodes/why-oscar-health-s-great-quarter-isn-t-what-it-looks-like
Duration seconds: 683

## Resource

Oscar Health looks like a screaming buy — growing revenue, growing members, positive free cash flow. So why does the market keep discounting it? We ran the numbers. Oscar Health (OSCR) just posted strong headline numbers: member growth accelerating past 3 million, revenue climbing, free cash flow positive. Health insurers don't get valued like typical growth stocks — and free cash flow is one of the most misleading metrics you can use here. In this episode, we break down why insurance float — not free cash flow — is the real driver of Oscar's balance sheet, how the medical loss ratio (MLR) caps profitability by regulation, and why receivables and payables to CMS matter more than most investors realize. We also walk through two reverse DCF scenarios on GAAP earnings per share — a 10-year model and a more aggressive 3-year model — to see what growth rate the market is actually pricing into OSCR today. Think of it as a masterclass in valuing any financials-driven business — insurance, banks, specialty finance — differently than you'd value a software or semiconductor company. We also give a first look at the new investment thesis checklist tool and segment/KPI dashboard inside Semiconductor Insider. TIMESTAMPS0:00 - Why Oscar Health Looks Cheap (And Why That's Misleading)1:04 - Revenue, Member Growth & Free Cash Flow Overview2:00 - The Problem: Free Cash Flow Isn't Real Cash Flow Here2:40 - Medical Loss Ratio Explained: The 80% Rule3:03 - Insurance Float 101 (The Berkshire Hathaway Playbook)4:38 - Reading the Balance Sheet: Premiums, Payouts & SG&A5:24 - CMS Receivables & Payables: The Hidden ACA Liability7:00 - Reverse DCF: 10-Year vs. 3-Year Growth Scenarios9:07 - Building a Custom Investment Thesis Checklist10:40 - Final Takeaway: How to Actually Value…

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/chip-stock-investor-podcast-6441813/episodes/why-oscar-health-s-great-quarter-isn-t-what-it-looks-like/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/chip-stock-investor-podcast-6441813/why-oscar-health-s-great-quarter-isn-t-what-it-looks-like.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.